Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD11 pseudogene 2 (ANKRD11P2) refers to a non-functional genomic sequence with high homology to the ankyrin repeat domain 11 gene (ANKRD11). Related pseudogenes exist on chromosomes 2 and X, but do not encode an active protein, nor do they have recognized biological or therapeutic roles[3][5]. The protein-coding homolog (ANKRD11) is a chromatin regulator involved in transcription, neural and skeletal development, and is linked to KBG syndrome and other neurodevelopmental disorders[1][2][4][5][6]. However, ANKRD11P2 lacks direct evidence of expression, function, or disease association in the available scientific literature. Critical Notes: - ANKRD11 (not ANKRD11P2) is a well-characterized protein-coding gene and is a therapeutic or research target; all disease, molecular, and functional associations are specific to it[1][2][3][4][5][6][7]. ANKRD11P2 is a pseudogene and does not serve as a therapeutic target, does not have direct biological function, and is not part of major molecular families. - ANKRD11P2 is not a receptor, enzyme, transporter, transcription factor, nor any functional molecule. It is incorrectly presented as a target for therapeutic or research purposes. If you require structured information about the biologically active protein-coding gene, refer to Ankyrin repeat domain containing 11 (ANKRD11) instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD11 pseudogene 2 (ANKRD11P2).